Reckitt Benckiser Group plc
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex,…more
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex,…more
Latest RNS from Reckitt Benckiser Group plc
- equity_issueEMTN Programme: Admission to Trading
- buybackTransaction in Own Shares
- final_termsEMTN Programme: Publication of Final Terms
- director_pdmrDirector Declaration
- tvrTotal Voting Rights
Analyst consensus: Buy
As of 10 Nov 2026, 19 analysts rate Reckitt Benckiser Group plc a Buy, with 79% buy ratings and a mean price target of 6,270p (range 5,382p–7,660p), +12% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 5,707p against a current price of 5,586p (+2%), based on EV/EBITDA.